Vnitřní lékařství 7/2020

PŘEHLEDOVÉ ČLÁNKY Riziko kardiovaskulárních komplikací v závislosti na hladině glykemie: od diabetes mellitus k prediabetu | E25  / Vnitř Lék 2020; 66(7): e20–e25 /  VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 22. Lustigová M, Čapková N. Prevalence rizikových faktorů srdečně-cévních onemocně- ní v Česku z pohledu demografických charakteristik – vybrané výsledky studie EHES. De- mografie 2017; 59: 162–169. 23. Wasserman DH, Wang TJ, Brown NJ. The Vasculature in Prediabetes. Circulation Rese- arch 2018; 122: 1135–1150. 24. Stengård JH, Tuomilehto J, Pekkanen J, et al. Diabetes mellitus, impaired glucose tole- rance and mortality among elderly men: The Finnish cohorts of the seven countries stu- dy. Diabetologia 1992; 35: 760–765. 25. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose con- centration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215–2222. 26. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardio- vascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Di- seases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2006; 28: 88–136. 27. LeeAK,WarrenB,LeeCJ,etal.TheAssociationofSevereHypoglycemiaWith IncidentCardio­ vascular Events andMortality in Adults With Type 2 Diabetes. Diabetes Care 2017; 41: 104–111. 28. Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all-cause mortality: systematic review and meta-analysis. BMJ 2016; 355: i5953. 29. Açar B, Ozeke O, Karakurt M, et al. Association of Prediabetes With Higher Coronary Atherosclerotic Burden Among Patients With First Diagnosed Acute Coronary Syndrome. Angiology 2018; 70: 174–180. 30. Vistisen D, Kivimäki M, Perreault L, et al. Reversion from prediabetes to normogly­ caemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study. Diabetologia 2019; 62: 1385–1390. 31. Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Preven- tion Outcome Study. Lancet Diabetes & Endocrinology 2019; 7: 452–461. 32. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2020; 41: 566–570. 33. Armato JP, Defronzo RA, Abdul-Ghani M, et al. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES). The Lancet Diabetes and Endocrinology 2018; 6: 781–789. 34. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes – 2019. Diabetes Care 2019; 42(Suppl. 1): S29–S33. 35. Shaw JE Prediabetes: lifestyle, pharmacotherapy or regulation? Therapeutic Advances in Endocrinology and Metabolism 2019; 10: 128–133.